Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-015241

EVP, Chief Legal Officer gave up 185,641 shares (to pay taxes)

  • EVP, Chief Legal Officer acquired 426,819 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise +22,645 33,251 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Shares withheld for taxes −10,147 $13.31 $135,057 23,104 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise +38,226 61,330 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Shares withheld for taxes −16,598 $13.31 $220,919 44,732 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise +24,258 68,990 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Shares withheld for taxes −10,533 $13.31 $140,194 58,457 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise +305,810 364,267 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Shares withheld for taxes −132,783 $13.31 $1,767,342 231,484 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-04 Option exercise +35,880 267,364 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-04 Shares withheld for taxes −15,580 $13.30 $207,214 251,784 D
Derivatives
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise · Restricted Stock Units −22,645 0 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise · Restricted Stock Units −38,226 38,227 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise · Restricted Stock Units −24,258 72,774 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-03 Option exercise · Performance-Based Restricted Stock Units −305,810 0 D
Daly Jason B. EVP, Chief Legal Officer 2026-03-04 Option exercise · Restricted Stock Units −35,880 71,760 D
Loading xslF345X05/wk-form4_1772746340.xml…